Alice in Wonderland Syndrome (AIWS): prevalence and characteristics in adults with migraine

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Mira P. Fitzek
  • Jasper Mecklenburg
  • Lucas H. Overeem
  • Kristin S. Lange
  • Anke Siebert
  • Paul Triller
  • Lars Neeb
  • Jens P. Dreier
  • Kondziella, Daniel
  • Uwe Reuter
  • Bianca Raffaelli
Objective
Alice in Wonderland Syndrome (AIWS) is a sensory disorder characterized by a distorted somatosensory and/or visual perception. Additionally, distortion of time perception and symptoms of derealization/depersonalization may occur. AIWS is frequently associated with migraine. However, its prevalence, and clinical characteristics remain poorly understood. Here, we investigated the prevalence and features of AIWS in individuals with migraine. We hypothesized AIWS is more frequent in migraine patients with aura than in those without aura.

Methods
This was a prospective cross-sectional cohort study, conducted at a tertiary headache center. Participants with migraine filled out questionnaires, providing details on demographics, headache, AIWS characteristics and the occurrence of transient visual phenomena such as fragmented vision.

Results
Of 808 migraine patients, 133 individuals (16.5%, mean age 44.4 ± 13.3 years, 87% women) reported AIWS symptoms throughout their lives. Micro- and/or telopsia (72.9%) were most frequent, followed by micro- and/or macrosomatognosia (49.6%), and macro- and/or pelopsia (38.3%), lasting on average half an hour. AIWS symptoms occurred in association with headache in 65.1% of individuals, and 53.7% had their first AIWS episode at the age of 18 years or earlier. Migraine patients with aura were more likely to report AIWS symptoms than those without aura (19.5% vs. 14.1%, p = 0.04). Participants with AIWS reported a higher incidence of 17 out of the 22 investigated visual phenomena.

Conclusion
AIWS symptoms appear to be a common lifetime phenomenon in migraine patients. The correlation and clinical parallels between AIWS and migraine aura could indicate shared underlying pathomechanisms.
OriginalsprogEngelsk
TidsskriftJournal of Neurology
ISSN0340-5354
DOI
StatusAccepteret/In press - 2024

Bibliografisk note

Funding Information:
The authors declare that they have no conflict of competing interest with regard to the content of the manuscript. Financial interests: MF reports personal fees from Novartis and Teva. JM reports personal fees from Novartis. LHO has nothing to disclose. KSL reports personal fees from Teva and Acticor Biotech. AS reports personal fees from TEVA and Novartis. PT reports personal fees from AbbVie. LN reports personal fees from Abbvie, Allergan, BIAL, Lilly, Lundbeck, Hormosan, Novartis, and Teva, and research funding from Lily and Teva. JPD has nothing to disclose. UR reports personal fees from Amgen, Allergan, Abbvie, Lilly, Lundbeck, Novartis, electroCore, Medscape, StreaMedUp, and Teva, and research funding from Novartis. DK reports personal fees from Wiley, and research funding from among others the Lundbeck Foundation and the Novo Nordisk Foundation. BR reports research grants from Novartis and Lundbeck and personal fees from Abbvie/Allergan, Eli Lilly, Lundbeck, Novartis, Perfood and Teva.

Funding Information:
Open Access funding enabled and organized by Projekt DEAL. Dr. Dreier was supported by DFG (Deutsche Forschungsgemeinschaft) DR 323/10\u20132 and Era-Net Neuron EBio2 (Early mechanistic BIOmarkers for late Epilepsy and long-term Brain Injury Outcome), with funds from BMBF (Bundesministerium f\u00FCr Bildung und Forschung) (01EW2004).

Publisher Copyright:
© The Author(s) 2024.

ID: 394524090